Show UniProt / TrEMBL protein name		View in Fasta format (DNA)		View as list

# Borrelia recurrentis A1, A1

>BRE_1063 uncharacterized conserved protein
MDIIMDSNEDLDKIYSKILNLLMIKSLDFNFEEFNLYIGLLEDVLLSRGL
GLKDLNSSNVFLLIYYFIGCELKKRGKLLYFDLGKIKSERLGEVSVEYFD
DALHGEVLVNDFCSAFNNLVEDIKTNRKVLIGVV
>BRE_1073 putative lipoprotein
MQKWLKSIIILCSLLSCNTQGNKPDNKTNFNLIMPNTKAKATTKKLNLDV
NEALIFLINILTNNTIANNIKIYTDEKINAFIMYFTPQQIDEMVTNIIKV
IEIKKNIKDNIKILNDDDNHMPTHLKMSLINQLNEKLEKEINNYKIAIKI
AANHESFDVAKINIQNIPITNITKIKDEAKRAVDVQNTIIIKANAKAIEA
KLNPSEKDALKFITETLQDTTINKNNTIYTDTQINKFINYLREQQIKEMV
ENTLKALEEIENAKANIKILHDYKQQKAELSKQLTEEINNYKIAIKIAAD
HESFDITKINIQNIPITNITKIKDEAKRAVDVQNTIIIKANAKAIEAKLN
PSEKDALKFIIETLQDTTINKNNTIYTDTQINKFINYLREQQIKEMVENT
LKALEEIENAKANIKILHDYKQQKAELSKQLTEEINNYKIAIKIAADHES
FDITKINIQNIPITNITKIKDEAKRAVDVQNTITAHLPNNNEKYAYALIY
LTKTLPEGNSYTYDKFNIFILNIGLDKTKDMLTHLAKEFPKVSTTENAVM
SYIKDISQKSKLNADLQEAHKDLQKSIRTAFSNGTLPLDAIKQNFKKINF
HKFEEIKAQADLILKNQFP
>BRE_1009 hypothetical protein
MKLHYILLCRLNHKRRILMQRMRVIILLFSVCVLSCGQDRVITPDKYGMR
KIRSFPTITPDVKVKSGNSGLTSDAQVEVIERFNNRTKRVPKTPKKAYAK
FKRSYDKLKRFYNRRPKNFNVSLFDSIRKKFGVDEKQGFKDSVYESLNGD
IISLNNLEKILMLTKGSGDAYSVELNSRPLLIKLCGIVGSSIFSIMNETG
AILSKDHLALMQDSQDVDGINNLGNKMDDIREKWREMVKLLQNIINNAAR
FATQEDVIQNLQPIIDLDTLRGDQKSTSQLCSLKNELLDLCYQIEEQVRK
LRLGLVKSN
>BRE_1004 hypothetical protein
MENLKISLLIILYMTSLIHLFAQDKVKIKLPIVTEWENKLNELKGDPEFI
KEVEYVKSLPEGIYTPSRDIYAEADFRVYCEVIFDTTKCYPPDGYFGKEY
EPLFAKTYNFLKVLKRKDPAKVIYLIRTMKDVAGSFGDIQEYDNWYIYNT
KGVQVLDKRMKDIGEVLKIYRKTKKQYFSSMDMLDINDMDNSIAELIIQL
EEIRKSIEYVTKKMS
>BRE_1050 p23-like cell envelope protein
MIRIIIALLAIVSCSVQQNHNLEKQHKRFIQPTYNKFKHKRTPGNIDPDN
DITKYQSEQLQIEEGSLDVCLQVTPHSWWPFSSNNCKITWIKNNFQKIIE
TDTQKESKLLQGKLHYTYIVAPIKSHNEYTKYVMPLILFASLVDYIEIIS
FKLKCRPNLNLDFEKGSMQNLRNRVADQVNKAVKAQGYKKAYLYGTINML
YPEGGKDLINAFKSQYKNGNWSFMEAEITIKDTLDHKTTTQSILLDSIMF
NEFLKLVIKKHPDIKEANNQFRAPVD
>BRE_1076 hypothetical protein
MKLQIYLEVRMGFINKIGVLNIFFIFLNVLPFSYQFCGAMVLGDFSPNNK
ICNLIDSVFKSATTTGADRMVMSSVVNFGFKIKGAIYYLGSDDVAEVISD
IDVNTNREVVGEVVGSGVVGMQDENGVFNFKDYGIDIDEVTSEKSNSDVI
QNSNIIKPKLVKKTQNNKDLGDDANDTDESFGNISDNIVKFSSRVDKFLG
WMRDDSVKWKELITLMQKFYNKKRQEIRKKMAGWHLREPFFVDQNKGTVH
LCDTYVVDMKGDNIKIFLDDYSEENSSDWSWACIRFFAREFLFALTAFGN
NYDKIYEHLKTFFEGSILESALKDSFKK
>BRE_1036 hypothetical protein
MENVTKYGIILLNRHLNNENLAKIKDYFKFEEGLVTFIDNIMFHLDYFMK
AREELISDIKHFVNEAAARRGDKLMMINYLESLIDDGILLNRILIGIVDN
VFKIEDKLNEIFKS
>BRE_1049 p23-like cell envelope protein
MKKIIILLALFIIILSMASCFLDDQIDYSKVQLDQALSNIINKYNHNKLK
DLQKEKVEEEEQTTFEVIEGQKEQCMCIGCWFWCSCPKPKCYITWMKIKA
KEIVDQDKKVIAALKDKLRYSYSVSPIKYNNDYSKYVMPLILFESMDENI
EVTSFNLTDHKNLDFNNKRVLGGLIQGIPKVEKSSEEGYQNVYPYGILNA
TAPTGGEELISAFKSLYKNGKWDFMKAEIKVKDKTKNQESTHNILLDGKL
FNEFIKTVINNHQGTTTANTKFQVPINN
>BRE_1058 uncharacterized conserved protein
MRYKLKILTKHKAYEYVIRDIPMYDWDSILGFDSSQETLRRELNNLSTLK
KISSLMISASFFDEFYDIINDNKEYSFLYKYPLPTILFAIEYSLVEKISG
LQKPSLVYIESFQDSDGTFVKYSYIDERWNYDDLVLREVG
>BRE_1008 hypothetical protein
MHQMYRVIFVFSVFILCCRQDRGDISNGQLMNRDRKIYGSMPATVLNNTH
LEETKTSGTGDLRHNKLGVDLSINIKPVGDLSASRRTENAEDANTLTPPP
NVLSNGLPDMPSNREKTPDVVDEEKGSDYTEQKQRTFEKSYDALMTSIDN
LKTLYYYRSDKFSEYTLDKIMSDVKLHYSRTSNNNVYAVLKGDMHILSRL
EIIMRYSVGSWSSEYNYPHYFFRILNNLGGLIFKIIDEKGEIFSDENLSK
LKNSQDFGCIDVMTDTLSVVHKKWSELVKIVQDRIVEASNLDSVFFIVEY
LSLIVDVYDTPKNFEEVKIRILKDELTNLRSSLRDKVYELTRRQH
>BRE_1054 outer membrane protein
MFMVKVRYIVFLFILFSNLNSVVSPSSPLVRPFDFSSWNFERDIEEAYEA
SYKVVDGILVNVDDPNKNVKSKHILSRISELEGYYKCLVNVIRDNIFLQV
EDEFLREYGQYFDDDVFTETDNRFKQLIEIPMEDTFGMYRHRVLTFSNKT
WIKNPDYTKLFIKLQLKEIEFVEDYIKQRLGIKLGANGQKVNHQLNDQRY
GNNSMENEYDDASQERRGAVVPGYDRGSRPVSRVQRPNYDRESRVQQSVP
RQEMPRSVVSRQSSGRPNVSGSKVVKPSSIKRGNLRPSSIRPSLRRPGSD
IRPNFVRPIVRPLGEKPVTYKRGSKDSGDE
>BRE_1040 uncharacterized conserved protein
MKNFSMTLVCVLCLLLILFIMFGWDSGVKYHSEFQRELERSGIRPLNPGE
IKDSSIEDKISKYERSTVQDNSDETLDDENLLSEVPDSHETREQAYDELE
NKVREFKNEFLDRSLRFASGKHQFSMPFFERFAKFDGDDKKDIVYSSLGY
DVDVIRKLETLINKVDPNVPSYLSRLDKGIASGLLDVLYNVTYYVREVVI
NNHLNLFNLGNIKTSSLITADDIASINVLIDTLMHLRRNLTLKLGRYIVL
AESKTDKLEMEAVLRKIIEQNGDIRRLIAKIMFISQSIGNLVNVQTNP
>BRE_1060 uncharacterized conserved protein
MPQDTINVNLIEDKVKLNNIGYYNPLLIYKSDVLEKGHFVLTSGSFRDFL
TSMSVRDDVKTDVGKVKLAADQIEFLIKSSNDFFNEEGLRSFDFYIYENI
EDVVKFLKKNIHVVVIFVANLEENFGAEWNMIKGLVKFVVFSTNLNRLPE
FLEALAVSQRDGVILVYDNGADNLHLKFVAKYLYEASMFHSVNPYGITLR
ASPIYDATLINNLRRNNINFYSLLNETGRDGVLAFKEAVDCSSMPIDEAF
TYCLLKNESTHELIRIWNRNHRQNSKLSELKFADGKPNAYTAGLECLFKE
FKERGLIVSFGDIKFGLKRDNILGLDLSIRVKYNDSFKSVVLNISSDDIN
DYLRREVD
>BRE_1069 putative Viral A-type inclusion protein repeat
MLVFKIRLNKWRMFMQKLSQIFIILCLLTNCDLKTKQRVDDRGVDEQNPK
STQQQTEPTDPEITFNQEAQKIIQKLNPEENEALMFVINALYNKKTDKDN
KAYTIKQINDFIIHLDAEQIREMIANTIKVLKETNIKVLKDKKETNEGFE
SIRHYPHGKELNKRLKKIINKYMEDIQQAANQVSFDIAKINIQNTLIDND
EIKKIYDEENRAIEVQKMHDRAKKEDKDSWYPYYAFLHFVIIPEKSCTHD
QFNQFILNRGPNKIKTIFKKLTPALKAEKSAKKTIFQIADKCQQDKLYST
LCSYAINSRKAMIQAIANGNLDFDQIEANLMQLPSYLDQIKALQKQAKDI
LKDQKEETK
>BRE_1057 uncharacterized conserved protein
MNRSEILNEYLNYLKYLRSETCKYYFPVLMEVCTFNDVKKFKYDELMEIN
KIANFKLKKKVYEKFLVSKLLG
>BRE_1019 hypothetical protein
MFKVYFLIFILNILLLCCKQVSNDLINTSTPLAIKTNSINKRNLNKNKLQ
TSKLTKETEYTTLIKSLNKFKALYNCMPTKFHDPLFFDINKKFNVTYNNR
DHKNPIYSLVKGDTNTLHNLKKIIIKFNTPAEYYTSMIGDKLIDRLSLLA
FNIIFNTIDINNGVFKNTNMLKLQYSKDEKDLKELAVMLDNVCVKWDMFV
EQVKNIINEASNLNIKSNVIHKLIQFYDLDLNNPNQQCKYDDKLCNLKNE
FLNSYLKTTNKIKSLI
>BRE_1093 uncharacterized conserved protein
MDIKIDNEFKIIFNNDLKIVDGLDERKQRLLLYLKTPIGSLYDKNYGLDF
NFFIKLLKNQKEEEIKIFFANALKTLDIDILNIKIKKKNNITIFFSWRYC
KYGI
>BRE_1061 uncharacterized conserved protein
MLLSLYESQTFLVKILFEFKDYLKKHSLKVKIINSYNPLYLNDLEINGSY
LLVIRPEGFDSLDVRNFRSGSFYENVNEFGFKFILFFLGFVGEVGELKIY
VGLHTIYEYFLEFLHENAFKFKFLKQNPLEKEYDLSLNYYLKSTSDLRNG
GFVKTSCNGLKGVLGLSQNYRANIQIVENKID
>BRE_1103 uncharacterized conserved protein
MIRQVFYALLLLLVLIMNCNLTSKDVSDFDGTSLVVNSLIDQTLDKGSRL
LEKYEEGGIDSIDLELYELLDLFGVSKNGKMLIFYIKEALCDSDIVDAQG
QCEIYDYIQFYELLNNLGADKIIEIVNHLLGTFNALREAELAISKVSDGD
LKREMQIRFDLKNKAYKLDLKKVFSASVLDELYNQIISYDSSYIDDFINM
KIDALSKYSRN
>BRE_1052 uncharacterized conserved protein
MQSNYEISRRLGNLSEGLAFEDAKRYLQDNVFICRIGIVKKFDFEKQEGI
VVIEEYEDLNIISRNISNLKLELVEGDRVVLLQSSINIFNESDNNYFDKH
YFYILNALTLRNVGISVEKFKIDTKELDVTSEDSSLNLKNIICDGEHSKI
SLKSLVIEAGNIELKGNVYINGKLFESHTHSSGTITYINASGAPTLASGS
TAGVS
>BRE_1100 putative lipoprotein
MNEKKSCDVLFLLLLLFGGCGVDTQKKQGLATDSGVYIPSKVVAKQPDTN
FTSLTRFEQSVASPTTENREHKPVNYEGREEDLKPDDSEASGITCDDSSI
STLKDKVVEVEESPEKEEARFFSLINRFGLSDDEKMFIGIIKKFVTDVNV
GLNMGYKTYSNSEFYNLLEKLGATFVKRIVKSLKPTFIVLNNAQIAFDKL
KERNKNHFQMTFNMAYNGFARDLKSMFNKPCFADIYNSSLQYNNPYSVQF
ISLKRHFDYMNGDEK
>BRE_1043 hypothetical protein
MRNYMRKSNFIFYVLLFGVMSCNLDSKVDLSQLQASLKTLMPQDASFVED
GKNLSDFKVLLQEYKDKVKDSKDKFEKSGHKFDFCNKVVEGLEIENEFNE
DYVYEAVSYNVDVLKHIDAIVKKFDAKVVPKEDVVQNNDKDADKDDKGDD
KKYLLSVYLLLYNLNSDARFLSDFVKQNFSDENLDKLAKIEDVEKFTSSL
REFLDSKEKLMSVNNKVILEIDLNGNNDEILDQLNKINEKNFVDKNEVER
SLNNGTYINDVVKNL
>BRE_1007 hypothetical protein
MQRVYRLIFLLSILIFSVLILCCKHWGDETHGTNHVLHSSLVRARPESIS
SSTVKNVQSKFAVDDFENKKLNLDLEVGLTPSGHFVINQVRTTDSNKPNL
KTNVVDSLGSDVLDKDVENPSQDKEVNKEEELVQVEEETEILKKNYAMLQ
AKIEELKTLYYSRPRMFDENILNNIERKLDASYSELYKNNIYAVIKGDME
ILSKLDLMLIYLFLVWDGSYTYFRDLLNVLQHISMSLIFRIINENGSIFD
KSNLVALQSSKDVLGLKELVSNLDSICLKWNRLVGLIKDQIVQASIFYHK
DELIKHLSPIINLFVRSDNYKNDPIRLLKDEILDLIKQVETQVYKLKAEE
>BRE_1021 putative lipoprotein
MNVIYKIIFILGVLFVCSCKQDGEQDISGDFTEAYIVLLNSYNRFKSLIN
GPKGFSNSFFDDIKRLFNAYVEEYAQNDFYASLGFDAVAIDNLKRIITTF
NLNRYYYNTEVGNSFVHRLRQFSLKLIVPINNLLQKNDNIGVLKDSNNME
GLKELALMLDDVCVKWGMFVGQVKNAINEASNLTVKNAVINKLEILDNLE
IENPNQQCVDVQGINNKLCDLKHELLQLFISIKDKVLELVKNVGKE
>BRE_1031 hypothetical protein
MKILGLIFYLLCVMNMISCRYWSLEERMDKDFNQKDEVGGTRNLKKLDKL
NQSEVTNLSFISSDLWDEIFNHPEDSVKSSDYGEQIVFPENEFDFQLDIE
KQQRIDDFQTNDAREGVNGGDEIDKDNLEKTDRVDGNKILEEREVEFRDN
FENDDSDLGGEGKVYDFLLEKVQTYKAKFLNERDQFYLTKLFFNIPFDKI
SSDFSFEEEQDKVYSGLRYNVGLIARLGNLFDKLLLTNISNGILEVFDDV
LSVLSELSQYPKDSLELLNEEILANIRERDIDIKRISDALDNIVQLKEEL
VEDIRDNIESLGSIDDESEIISLLQKDFGEGKYKMKISVLREFAMLISNL
VIN
>BRE_1035 hypothetical protein
MDLREQNFDELKEILIGFREELENERYAFISKQSQLDINFKGVLDDIIYY
QSDRDKIYTMLGYDVEIIGRLGLIFSKLNFKHVYDRDTRLVMNLLNGLMR
VAHSIQTLFKDIFNQTKLDLLQLRDNEDIKKIVIYLEQFIEIIKDLMLQV
KAIIVSVASKINEDSILKELSRVVAKLDSKFNKGVRNIHYLLFDIIELVD
FL
>BRE_1090 uncharacterized conserved protein
MENEQDNTEESIQIKDFNRKIRVNENDLIPIDDIVEETYAIIYKNLLIQI
QEDTFYRGIEYFKQVIREIISKELLEYESHVDEMYIKTISKLIGLKNETN
KITLDDVLKKIKEILIQNINQAGDNINSSKISIYNPQRQDFELIGFQTFI
DKLKQIFAEITNLNNLKNQTDKILEQIKQITSITNNINTSYLKNHELESK
LKSIIPEMPEYKYPNMELEFLAFHPTNKQLYRLGIEYRYLKGIPNDFQYW
NIQPTHDAYYTLKEFYDKLLKIEITGEKVELRFPRNYKEQNIYLQIMLAL
TRDKYPNNTMTKIIYLRFSENSNASQYNIIYSYTGKQHNTTITLLDGWYK
LKSYIYNNDENQDVPHLLKS
>BRE_1034 hypothetical protein
MKSSFGILSNLLMKFKQELESKRVAFFSKEERISINFKGILNDIYYPSDL
DEVYEALRYDIEIILSLGRVFQMLNFKNMGDRDTRIVTNLLNGLMYVAHS
IQIFFEDVLNKAKLEMLKFRDEDDLEKITKYLVQFIDAVKDLMSKFRDVI
VVVASKTNEDDILNELQKVIASSDSNFNKEMRNIHYILFDIIELVDLL
>BRE_1070 putative lipoprotein
MQKWLILFIISYLLISCNNPQKNTKIATSNNDYHLKQTAISTTKPKTTNK
DQIANNIYDQNSQFNKLILNTTQKKTKYTFKNIVKKFDNQNIANKNIHKT
TAKQIADSQSLTPDFISNSTAQLNPEENEALNFLTETLKDNNIAKNSKTY
MDKEINDFIIYLKPQQIKKMIANIQQALKEIENIESNIKKVYDYKKNRTK
>BRE_1102 putative lipoprotein
MFGEKICVLLVSLVLIISCNLKSSDLAKDGKGLENSFGKSVVVGPLYEVN
RFVDEPFSPRVEYDTPAVRKGVEEMGMGIDIGDMDVELDNLLTRLNIQKE
DRDVFVYLKKVLCDPTITDDQGVYKTYTVSEFHDLLDSWGAGQVSVIRSK
LIRVFTSLKALRVLIGDCRNNILKQGLLNRLMFVKKEYERYLKKVFDSSD
FSIIKVSLEYHNPYYGKFGLIEIDASNFKDLTDVRDRYSAFVDDDQKRIQ
EIRNILTSANIARGQNLKTYSDDEFDILFSSWSNYQLKRVVRMHLGYMRR
ARDVKVQIGYFDDMKNIDIRTELKYRLVTSLTTWKLKLEDTLSQKDSGYP
EYLKQIFNKSTAVEIYDNIPFSSKYDINDYNFYFPFNDAYFLDIDRYYSI
RNEFISKYNKLSYAEKVAVEFIRNIVFNANIAADKGYKTYTDDYKFYLIF
ASSDYYFSELVQRQLNFATCQSYIEEYINEIKENPVRKNKLLQKRDELVK
KYHVSLKKFFHGVNEATFEFDDSSRKNYSEVWDIQLDFESFFDNIAVEGL
>BRE_1083 uncharacterized conserved protein
MVFKNKELKYSILFKSNLSISDIAKVLGVRESTVLKAKINILGEVASDLN
NFDTNACVNFDLDALARDATCQAYMLEKERDSFYKSFYKVANSYINSHFK
YKQIIINSDLKRLITLNEEILKLTKDINNNDKDLCKKLKLDLRYKIYKKN
RLSKKIILNEMKEDYGCLLKLKKIFNSKGLKLE
>BRE_1011 hypothetical protein
MIVCAIIFALNILSFSCAQSVTNLANVREGIVTGVSKSLTEFELKKQAYS
ELEHSFNKLKSLYHDSFKILNIPFLNDFKSKFNITNRQFHIDLIYAILRK
NYFLFNAWNGPDVIFVDGDSKNHILSDSVLLLLGIYTLVINTLSAILEQN
DVFGNYKLNKLKYSRDITGINEIKNMLYDMHLKWTEFSILLKNFINNLSK
FFYNDIQNYNDFFREEILLQLRKIRDINFIDKNQFYKDNYKICELKNDLI
NLRYQIEVKSNELIRVIY
>BRE_1026 putative lipoprotein
MGVFMKRMNVLICVVNFLVILGCVGPTGIQGLRGPDGRDGEKGQDHHGDV
ELLMSAFLVLKSSYNYNLGDVKKIKDSIEKSSIFSHVAFEDKFQSDKNKD
YICIAVKSNELVFEDVLHILRLLVGGRSSTSQDHNVAKNFLNSLLDSASY
IDEVINLNLFTPDFDLDRLRSFDRSVVFELNFLLMGMLGLRESIVNDIKV
LLKNPNLAILGSSSPSNLKVELAPIIDVGGNIYEKIYGDNDSLKSLRDLI
IKKINTNV
>BRE_1041 uncharacterized conserved protein
MQKMGFNIFNIVVAVGLISCNHSGKTGLAEGGGRYSSDCKSGFPLNELFR
SVHGAGAKKGFSGISDILLILENYKMDDRNRKLNLKRLVKNIDVFKFPFH
KMSLLKDSIATRDNVIASLQYKRKLLYSLIDILKMLNLDDSSSNEAMLAN
NFVLLLEKVSDLTLQLIYEDFNGACLDRLKNSTDRELVFVIYKRLMSRKL
LLNSFEFIINDLVENMDSLKAKSVDKEYVLNTFNKLVGNDNVLLSVFEGM
QDRV
>BRE_1014 putative lipoprotein
MKRIFMVVFASSILLLSCKEKEDNVINDQAGDYMDMKSLTSEQQQIYSAL
IASFNDLKALYDYKPEGFNISLFDDIKNKFGNTYYENFKETIYAAFKGDV
ATIDNLKKIVADSIETKDEYMSALNGRPLLYRLNELGNILFLFLNNDSVF
GNDGLIKIRDRQDIALFNEVKYMLDDMGVKWDELVSLLQNTINNVSVFAS
KYIETRNVADKEAMIAQLEPIVELKSLDANQSCKGVICKLKNEFMDLYSQ
IKEKSVE
>BRE_1056 hypothetical protein
MGLGIDATKKDLTYLSNFNIELDEYLKSKFKSKFMGSNDFFKKQIASLFS
ISNSNDFKSKDFGKVFAKDFSDDFISYLPKLSKSKLPNIDFDLIESPKSM
KNLNFKDLSMKPFRSREKNDNQENNFNLIKPLVSNSFLIPLVPMESNNLY
DNLPRLNSNLDLVSNANIKSNMLYSDIFKYLNVNAASKTRLNMLPGDFDF
KTKGGSVLGINDVTYNKSETQKIKSMLASTGKFDTQVDINDFIRKTAGFK
SLLFNDQQKSVTDIPKMFFEMVNLASNFKGKQKPNDNDDAVSVVYKLFND
NILSPFKNQLTKSFATIKEKRTDYIKGSLGNSLGAPLGGLASDLFSNLMS
QFGTKLDVMLKDFNLKKIIGWNSDEEKSEDAEQDVVDKTSLKIEPEANLG
TNLDLDSLKFNDVCNDLNVILIEIRDSIKQVCGMDFERNVLDPLSVYFNN
VENAINALSDAITRNSQGGSFGSNINDSKIGNAISRIP
>BRE_1059 uncharacterized conserved protein
MMKDYYSLDLVFFSFSGVLIDRGKLQYSTSPNVMATASTEERNVPIPSFR
DPRTIIHIFNLEITKGSFDYKVLTKLSNEQFYGSSYKRDKLKSLVFNDQM
GLKIISNSAFFSEIPSRTYASGSDTVNFVIHAINCEVERS
>BRE_1048 thymidylate synthase protein
MHDHVDAAEEVLDREYKVLDKGFLRLIDYMGSDERIVNSARVSYRDSKAK
RDSAALIDYLIRNEHTSPFEQVVFTFHVKAPIFVARQWMRHRTSRINEVS
GRYSLMREEFYVPLREDIKTQSLINKQGRSDEEIDIDVAISFLDGLDESY
KNAYKIYDDMIKKDVSRELARITLPLSLYTEWYWQIDLNNLFRFIKLRSS
GHAQKEIREYANVLLDIVNLVVPLATSSFKKHVLEGVMLSSEEVCEIRKA
LDLTKLNLSQKSLDRLKEKLNL
>BRE_1024 putative lipoprotein
MIRIYILIFMFYILNLFLACKVHNDSADDIVVMNFDDLSQSGNTLAPSQL
PPIRYKYPQANVVYDQLMKSLYALKSSYSENRDAFLSVKLQFDNGIFGIY
DMDFSDDEAKDDVYGSLKYNSLIIANLKRLIETLISANHKDIALILLYRL
SASAIYVREVIDEDYGIFSQDNLSMMRCSNNITGINLIKSYLDEMLKLQN
TIVDEVKNMLSGAIDVINDNDKFLLKLNLITGSQGYIREMINGLKSLRYL
RVALEEEFDNLKLCL
>BRE_1077 uncharacterized conserved protein
MFIRSKMLNEVLKKKSGRYYHSGSDRDMVRKITYYENLNLNRVQKFSFAA
YYINEDSDEFKSLQNEEREKILAPYPYFEFHFAVADNGYLMDFKDVFFSW
LDGDRVFMYDNKLDVDFKSSDVPYFKFNKSNDLDSKIVGEYPVNVINYFS
ISINEALFKLLLKQKTLTITLISADDAKYNISVTNFLSSDDFSVFNKDED
KVEDIGIDEF
>BRE_1095 hypothetical protein
MEKDFYNSVLFLLLLTDMSCGLSTSTSSSKFPDEKLPLKKFTSENVDAAK
PGFNSQDLESKFDLKERRVEAGGRQGGIREEKPEEIESIKNFYSALMYND
KVVFHSVQKMASGFEGYSDSEEYKDDQPRFYRVWGNLGINKLSHIMSEYS
RLNKKRSDIQWMMMNFDIRKIKEHFNNKLNDCDRNYALEFRGAFQKDDFN
TIYDGIVSVMKAYEENLDVFESDYERLRIFKRIHSGFSVKLRSSFDYISN
ELTDFNVEDESQSKMYFYYDFCVLFGDETGNNRYLQFVEKFEPIFELMSS
LREEIKFEIEDDAVVSQFTEVFNELEDRFKLYLKEVFPRIVSDDMSFEGL
DSYETDFENLKARVMDY
>BRE_1037 putative lipoprotein
MKRVIMVFLRVNIVFLLLMIFISCVSEYSGFLDPDARKVYKAFKNKVENY
KIIFLSRSDSLLNFIDSKISFFTGDKEAYSDKLLYFNEDTTKRVIFATLG
DDLGVVKRLIDILHQIYVLIRMLVI
>BRE_1015 hypothetical protein
MTKVGLMLCFFAVLFLCCRQGNIMTEDLEDSNFEETKERKKNKRGRFGYY
DLNSLEQAYDELSTSLNNLRSLYYYRDDGFNISLFSDIDDEFRIKDNIFI
MDDNVYAVLHGSIDVVGNLKKIVIDLNEDQSSYMYKNFNGHSLVAKLDHI
SQFTIFAIMKAYYDVKGNQLLEKLKYSKDIEGLKKIKLMIDDFCVEWAKL
VAEVQKIINDVAVFADAYIKIKNDRFKDNEKISYMKSIEDGLRPIAVLDI
NNFNQVCSDSLICKLKNELVRLANQILDKGDDLLNALQPQNSTP
>BRE_1030 uncharacterized conserved protein
MKLFGLLTGTLVYSVGSIVKNRPVRKVFDLKRNTSSGNVRVQGSFNISDK
EQVFYTLKTRVIAYREEINGLYSQFNSGKFLLNIPFKKISSDFADSDKQY
KIYSSLGYDMEVIKQLGNVLNKLDFNSPHFINIDADVAYKLLKFLNNITD
YAKTLVNYYLSDETLLHIKSSKDKLRITEIYNHLEDFITLRENCMSKIKL
QITYLESKITRESVLTGMKEMVAYEGEIGQDINLMSTIAITIWSLS
>BRE_1003 hypothetical protein
MKNMMIKILVLLLMGLFGSCHLKGLVDISTEEDGEDIKFKIRFKESNEFD
QNSNNNNEELTNLLVNKFGLSAQQIKAIQHLRRIVVDFDKEDKYTNNEFY
QFIDCLKGLELKDLADNILYIMNEIKEVIKFIGAVKNDKKKQELFLEFKQ
IEDDYMSIIRDSYSRPVINRAEIIKIYNLIQKNKFETFKYQRIRAVDFAS
TRENKELIRYIKEIIDNTQPSEETAQINKDRHYTRLIFKIIESVYLNEDF
LTSFSKKISELRKIIDSVMLVIDNEQDTNKKQEIETQFNNAKEQYESDVV
NIYMNFDHMKDRPEWSQFLGLQERILLHKNAFNNIITSS
>BRE_1074 putative lipoprotein
MQKWLKSIIILCSLISCNTQGNKPTNITNFNSMKLNIKDKIKTENFHIDA
SEALIFLINILTENTVANNIKIYTDEKINAFIMYFTPQQIDEMVTNIIKV
IEIKKNIKDNIKILNNDDNHMPTHLKMSLINQLNEKLEKEINNYKLAIKI
AANHESFDVAKINIQNISITKIIEIQDESKRAVDLKNEITMITNAQIIEN
NLDPSERNALQFIKKTLQDTTINTNNTIYTNNKIYKFINYLREQQIKEMV
ANTLKALEEIENAKANIKMIVYMSQQNHSYELFHKLEKEINNYKIAIKIA
ADHKSFDVTKINIQNIPITNITKIKDEAKRAVDVQNTIIAHLPGPDLQYE
DTIFYLKEIFPEGNSYTYDTFNKFILNIHLDKAKYLLTHFTKEFTMINNT
VKIVNRIKNTSHKSKLNFVIQQALKDLQQSMRTAFGNGTPPLDTIKQNFQ
NVNFHKFEEIKTKVLQIYREENSQIKK
>BRE_1051 uncharacterized conserved protein
MRYLFQLEGDIKNMKVLGNLLLFFVLFFCCKDEKYSGNFDLVYDSDDVAF
RDIIDSDFDIGVNFDNVSLEKLISDFDLSNEEKQAVRFLRSALTDSTILD
DMSHIRTYSDDEFYEFLVILNADKVKEAVADIVLTLKVRDEILDAIYEFA
DGKILKKIHLKYNLM
>BRE_1078 uncharacterized conserved protein
MILNIILMLTTFVFSCSRLSASEKITIHHNVDDSTVKVEMVLGNDLGGVH
VVYPYVSDKYKGNYILFNFDIKTKKALNLLRVSFNGIEVASKNLWRFYDA
PLELTGKEYLLPFDDSIELTGFYIYFDPALGEHLQLGDMSRT
>BRE_1106 hypothetical protein
MSVMINIMSIIICSVITFTSCSVDEKNNLSIQFPEDDLDEVLHDDDSEQN
QIQQDGDIWKHLNDSQEQVEKGSVAQRNDYEIIKEKVLEGSANGQQFVIE
NVLEVEKLDDYLLNNSFYSVQGIVDHIAERIVVEKMSEHSDILSTMSQKD
LLKVYKIIFKTNLNDGQKEALEFLEKALDSKIDKLDKIFVLDEDEIKNML
DIISNNLNIIREFESSNEFIFDSDVLDVVEVVEFKSDDVRVEYAEVKSDL
KGEIEPSLDDYLFVINAYFNDYDDIKVIVDNVNSIKILSP
>BRE_1042 putative lipoprotein
MRIVFILCVLFSILSCYSGDFGQVETLTKFEVVLREPLYSQLSEKVAKYK
MSLSDKEIKFQKAAYQFNIPFFKVSAAFDSENGDVQDSIYASLGYDFDTI
KILEMLFGKLLLEDPPAENEDTAVAIYLLALLRDTTDSVKVILNEYLNEA
FFARLGRSKKGINIVFKIELLLDNVMRMRKDVILKIMKAMKKIQSEINND
PDILSRLSDIFDENRDIKRSVNLISNISKQIEILSSQFA
>BRE_1072 Viral A-type inclusion protein repeat
MLYIVGYCAQNKMRLKTGGYLFMQKLLLILIISHLITSCNQQTKTPTLAQ
DKDDQDLIQTTRTKRKLKTILNTEAQKITKHLTIEENETLDFMIDILQDD
TIAKNIEIHTDQKINDMIIYLGTQKIKDMVGNINQVLKAIKNAKIKIQEI
NDNNPHKTELNNRLEKEINKHKVIIKNAVNYKSFDITKDDTQNATIDIIE
IIDIQNEATQAIDAQTKENALKDDHKNALRYLRSALTENNAYTHKQFNYL
ISNLVLDEIKDMLTNIAMELEHKINAINYITQINDTTQKTNLNNEIENAD
KNFKDLLKIAFNYCIPSPHVTKQNIKKIPPNNFIAIKNKAKQAIDNQGSL
SAITKLLDTQQKKALEFIIDILQNEKIYPYQKTYTSEETDNLIIYLGEQQ
IKEMVVNTVKALEEIEKAELNIQKINDNNPQKIQLNKQLNEEIKNYQQDI
KEAANYMSYDLAKINIQNIPITYIIEIRRAAEIQNTIVDHITPYDEYAQN
TFNYLKNAVAEQNNSRHDEFNQFILQIGPEKTKELIIPFAKKMKAIGYTK
IYINHIRDRNTKDRLKSELENAHQILKKSIKNIFQDNKPYFNNINQKLQA
ISFDIFKKIDEQALQIYRSQTG
>BRE_1005 hypothetical protein
MLVKWKYFICVVILVLSIVILKCPLGKIINNNDFLLNGDLDSFDNLNEKN
RLNTLDAYSALQVSFVKLRDSYIYIPVGFDEAQFDSIFQWNSTIKRVKYG
IYSVLKRDIGTLNNLNTIVTNLSSSFDKNLKSVVSDLFIGLWDIASSIDS
VLARRGYILSDANLIMIKSSSNTEIINDIRVSLEHMLELREELVRLLQNI
INSAAIFGINALDRIEENLRPIITLALGSTGLACSTNRICVINNELKSLS
NQIEDNVSKLKKEK
>BRE_1068 putative lipoprotein
MKIYKIFITLLIILSFGCDLTGLLGKDDEGKDRLQTIIEGAERFLGDLVE
EHVEYEYYYVDDQGNYFDEHGNVVVLNEDGTFVYKDKDVVIGAEGKGSIS
VNVDRDGKIDVSAVGEAMVVALDGAKKLVADVKAEVFGKPGEVQGDLVAK
VSDVVAKGSDFKSLVAKLEGDVNGEIKQVVASPVVKTRKPVSVSTKQNTY
KKPTNYSGHKMSNESRSKVYCQTYKVRPGERATKVYISDDEKKMFNFLEK
HLKDVISLIDKNSYSSRLKNRHDYKEKIKTKYEKLMGMSKEDTVAGDIRR
LELGRSVKKFYDFMKENAANSAEVKSLIENGVRDKSDILEKAGIKSSSDI
KNYYHVAALIDLALCYKDYSSSIRVFFENVADTLWYYADSSDKSADTQDL
IWMMEAKFHASNSSDLAQLKQGILGQ
>BRE_1001 hypothetical protein
MHVASPRILIMLVLLLVVLVVFFLLRFLSVLLLLILLIYHMPYYMPLLLM
LLLLELLIILILVLLFFLLLLLFPFLLFVPLTLIVFFFFVLLLVLLLPLF
LLVFFLLILVLILVLMLIVVLLVLFLFVILFPLFLLVFFLLILVLILIVV
LLVLFCLVSLLLVFSFLILMVFLLFFLSYFLFLFLVCLIYPVYFLNYRCC
LLIFVYQTPSSKLNFLE
>BRE_1055 uncharacterized conserved protein
MLDKKNVTSMILDIVNHILSLSASSNFIVLFPRPDFKGFVYVPQLFFIFP
KSKPTEESFSNASSEQGTVNVNLKEGEILSYNVVSNPEIINVSNGILSSI
HDKFLIEHFKKTSYANSVLEFNVNFVKVHFRERFKMGSYYSVYGPMIGFH
ELAIINSLKFRDAAFIEEINVSLQIKILKTFNISTYKG
>BRE_1097 hypothetical protein
MVKGRGFILLLFLILIIGCNFKSIKNSEMYKQGLSKKISFEDRIGFVNFI
FDDLNEFKISSENQEFVMCLERVVGDPDIMVSKTDRTYTKDEFYHLLKNM
NRDDIDKIMEFNVIYKDLKKVEKMIFDLKWYKLRYNLNFNFQNYKNIYFL
SLKRIFGMFSAGKNIIHPNDMLEHHSLILNKFVKDVENIKVFDSCFIELC
DNEKRVIYYMCNLMSNMSLAFDKPVLHCGYEFYSMLGNFGSNGIKNIIKI
HLDIIGKIFEIEKLYSDYLYDNIMDQKETFAFRNAKYSLRRTFNTMKTTY
DLSLKIIFNNKDINAIYNSLVNFNIVAFSHLDQLKADIFVFIDNFKLQFD
IK
>BRE_1023 hypothetical protein
MMKIICLIFFILSCLMIIGCSFDGQLSSGESYPYLRYAKSKSNKGGTAAL
SSFGIDIILQKQGQGNKGSLAYSELLQSINNIKKTLKFDCMEFDEAQFDD
MFQICSSYGYKIGYDVKVKREIYASLNYDVDSLGNLKTIIKSLVNSGEKK
GCDLVVNLLRYLSISTQYISDIVDEKGVILNVANLNILKRRDNVASLRDL
KSKLDSVLLQHNVLVSKLSAILERSMGIYSDLADPQSKARAISVYLSSMI
SRDSDIYNRIFNPFDAPVGANKLSLQSLNFAIIKKVEELTK
>BRE_1027 putative lipoprotein
MKFICMVMSITFGVLLFTGCDAKGPSGRMGLAGSDGVDGKPGKAGRGDLA
ILYMNFFNLYRSYTANREKFDSEVNNFDAEAFFSHSVFKDEFSGSNVEQR
NDFYASLKYNIEDIKVVEKVVEILVDNKDEIIRSNALHVLNVLVDSARHV
KLVLSALEPSLDVLNEIDDVEGISDLNVMLMMMWMGREKIIDDIRLLFSM
LKGYIDVGNPSMRNIMNSLNVIITSSGNIYKQVNLGVDSLFSLKEAILNK
IKNLKRRV
>BRE_1109 inosine-5'-monophosphate dehydrogenase
MMDKIVKEALTFDDVSLIPRKSSILPSDVNLKTRLTKNIYLNIPFLSSAM
DTVTESRMAIAVAKEGGIGVIHKNITIEKQRKEVEIVKSYHRNGIIRNLI
TINEDTSIKEARRLIVKHNISALPVTDHAGKILGLVTSRDIKYIADDNIP
VINAMTKKLITAKEDITLSEAKEILFKHKIEKLLIVDESNSLRGLITCKD
IDHVEHQEYFPNACKDMNDRLRVGAAVSTDVDTLERVEELVKADVDVVVV
DSAHGHSTKVIEIVRKIKSKYPNLDVIAGNIVTKEAAFDLIDAGADCLKV
GIGPGSICTTRIVAGVGVPQLTAINDVFEACKDTNICIIADGGIRFSGDI
VKAIAAGADSVMIGNLFAGAHESPSEEVMYNGKKFKIYVGMGSLAAMARG
SKSRYFQFESKDSSGKLVPEGIEGMVPYVGKVKDIIFQLKGGLMSGMGYL
GVETILELKRDSKFVKISSASLRESHTHDVLEN
>BRE_1064 uncharacterized conserved protein
MSESLFNNEEFVNTLRDSLFVDRPIPEYYHFFDNEQIETNDASLTSERVI
KWNSSIVDLPTLKVNDFSTVATIKFKRQVVLVNYLPFQYAFTYYAPDGRL
DIQAVNNINMREGLRYSLSQIHKLLSSHYLRGGLCFSGSKERTLLVDDSN
RETMYGLLNIPGQIDKNIKITKASDLIKACNDEIGNINVEDERGVPFRVL
TTPKIKAILLERLSNNNYSYKDVLFDSLRAINNDADIEFETTNLLDDEML
IYPKSSKLLLLKDGHPPILNAYTQMSSSNFRTSFLDFSIGSILASEKSIL
RFKISWT
>BRE_1006 hypothetical protein
MQRIYMLAFLFALLILCCKQGGGKIDNTGSKRDVSKDRSVRTINSDRIGK
TDDSLVGSTLDNQGGGATLGKDLPGGGVQDNVVDQGIVVVGDKGDGQDKK
RKTLEEESYDAFKTSFDRVKALYYYRPEGFNDYMLSDIESEFNFEYSLPF
KNNVYAILKGDIKTLHNLQKIVVNSHPEKVLEEYLSKNESHALISKLKDI
SDHIIHKLINGHWGDFSNYNLSKLAISKDIAGFNFLKNGLDEFCAKWGEM
TKLVQDVINDMAKSKDKNDILQRVGTITSLIPLNSNQQCNTRICAVKNDL
NVLRVKLGRKVEQLIREIYLWL
>BRE_1038 transposase IS605 OrfB
MSANKAYKYRIYPDANQKKYFSKVFGCVRFLYNKMLSDKKDYYEKNKQSL
ITYPSKYKEEFLFLKEVDSLALCNAQLDLNSAYSNFFREIKKGNRTQGFP
KYKSKKNRQTFRTNNQKNSIRIENDYIKLPKIGFVKLALHRKIKSNELIK
NVVVEKDTDDKYYISVAVECLDVKNNDKTKCNKKEIVGIDMSMRHFLVSS
EDEKINYPKYLLKNERKLKKCQRKLSKKQKGSRNRAKSRLRVTKLHRKIS
NQRKDFLHKLSYYFVANYKNIAIENLSIKGMQKGMFGKSVNDLGWHEFVR
QLSYKSEWSKSYLHKVDRYFPSSKLCNNCGIKNTTLKLSNTRWTCSGCNI
LHDRDINAALNLKAYYYKEIKTKAGTA
>BRE_1032 hypothetical protein
MLKFVYIYLYMKKGIFMRRINIILCILFILSCSEKNVDKSSENVNDADDK
DVCSNLSFIRLVGIDPRYVTFYKIHRLVKEYRNKLNGRTFKLKEGESKPE
FKFPLSKIFPVYSDANFIFESLNYNVKAIYGLEYMFHTLILPTYSSILGD
ASRFSIFLSYLDENSKVLKRLVNDDFNDETLERLKTTKTDKELALIYYYL
VDFIKKKASLDQDLEAILIKLVAEGADRETMLNVFNNSIVNIFLKFPNGE
LTIGLSNTRLIRDFEDLKSGPLTIIKCLIK
>BRE_1025 putative lipoprotein
MKKIYVVIFILMLLVFGCKIGERGLAGFVGHNGKDGLSGYDGRSDVELLK
VNYLKFKRMFHSNYESFKLKKEDFDKEIPFDNIIFDNEFKTESQRNSVYA
SLDYNVEDIEILKNLIARLFGFIDEDRKQNIKALLFSLRDIDQYVSAVIT
ASDVVISDFNLVNIKKGNNMHIVSSLNAMFGELLYRRASVIKDIRNIFSS
IKKFMEVASADRISSINGNIRIIGSNTGIIYKKIHVGDESLLGLKNDIIK
KLEELKETLWLQ
>BRE_1018 hypothetical protein
MKIIYKTIFVLSTFFICCCKQDKGEKPKIQDETKNFASGHTATNEETESF
EETDNIPNKSHKQLLEKYNKIQALFKKPEGFQSSCIEEIEGFFNTDYKHS
VNDNLYYTLNFDTTTIDNLKKIITTFGSKNDYPNPAIGESLVRNLSYLII
NIMRKIDNSFNRDNRMNKLKNTKNLESLNEIAKMLDDAYIKWNMFVSLIQ
KTINNAASLTNKQDVIHIFKMLNELKSYKTETCSTNNAEICKLKNKLIVL
STNIENKITELITEKVQH
>BRE_1017 hypothetical protein
MMRLIYKTILILSTFFICCCKQDKGEQNASTIKTDSNKSRHTDAWKEKMK
LKKAKQIPKTPEEAYDALIENYNELQVLLNTPKEFNSSFITEIGNFFGVD
YELFVKNNFYPSVGFDITTINNLKKMITTFNPTKKPDIPGLDVASIHQLS
LFTKELIRPIDNAFKENNQINILKNSNDVKTLNELINMLDNLYEKWDTIV
SLIQTTINEAAKLNKKDDVTKKFKLLNDLHLGNFNQICNENGVNNEVCEL
KNEMGKLSKNIKNKIESLIESLVDN
>BRE_1110 uncharacterized conserved protein
MILKRRRKMTRYNDVFILLMLISIVSCKNAVDGTKTVKDVNGNARNGSRA
KGDFVVANGFDIRNGPTLENNSGIDNANIRNDVDRLSKDDIVQLKTFITK
SVKYARSLCLLIQEYHTIYSFLKNYVYCVNGSGNCDNAKLTKESIDVIVK
MKVDNIVDKLENILNYFKIHNPKMSIDSIEQLKKIFKYHVNFVFDSNEIK
MDQVVDVVKLIINSYENVIDTAVNMYADMFSFIVSQCSSKKLAEISKNFV
RSIRLCMKENDSNNILLVQIMISVFESIFLNQGDIRDVKENARKLFFYRR
GKELSNSIDELYVVYHIARLN
>BRE_1075 expressed protein
MLCKFHLLLYIFISMSINLLRRLDMRYFGIIVLFLSISILCCKFYDIGDQ
KSLWNDNTGRAQDVKDFFSSDVGKMSSDIVGMKFDNKRANKGDMGKVQDS
LNGVVGKSKGDDKKEKVDGDAAGREAGKQDAVADGQQKDEQKKDDQKGDK
EQVASVDEQQKVNVEKIQDDSQGVEAREEGKQVLNSEGLSSEGQNLDGAE
QVKDGKQVEDSKEELQPNNSNDSSVDSSGSGSSNGGSGGDVGSGTLLGSA
AEGSVDVQGLDVVSSEQQQNQVQEQIQPQTQSQNDLTADLVTTDLVTDSL
EKLSLSGVEDGSRKVLSVSMPEVTSNLGLKDNSISTESIDKDEHRDVKGV
NLGSSLIDNRVTEGIVSGESLHFNLVSQSNMLDSNVVEEERKINVPTSNP
TSNIPVAKENKPVVSLKETSASKVQDIEVKGGQVSTSKSSTSKSSTSKAS
TSQTQNVKTQNVKTQNVKTRSGKARSNVESNSNFKSADKSLGKSVSVSGN
KIVDNVVDGIVHGIGDGVEAVINKADTLVTAAVQGAEAAIGVIHDAGTFV
IDTLQNMGSSILVGIDPTSYFSNSGNGMYLGLTSSESQAFARLEGYLKSA
IKVNGRAEDESKLEAGHKKLFDWLKKNDSDFVKRKELVRAIEGIYQFIRE
KISYSFELRNWVENIIWDMKARNIIFDINIKDQLNNDEIDVLISNTLRSD
KYRGTIVSLLFQALTDTLYDSVGDNYKSELQMFEDLKDAFSDSSPKGKNV
RELKSVIESRTQIVN
>BRE_1029 putative lipoprotein
MRVIRIYFLFCFIMVSCGKDLLDTLRKNPGVEGQLNVGGRSVYVLGKVDN
NGSVARSGSTTVNGSTNGGNPGPVEVTINGSEQSVIDELYNVLVNKTDRY
KATLVDEASLSNLAGNPYNIPFRKIDLQYDNLKRQSNFYAGLGYDVQAIK
DVGLIFNNLNLEKAMPSHDRSAEGKNDEWMLANNLLILVWQVGHYSEKFM
NHLDNASLSKIYRDKNKEKLLSISKCFDEFVKVRSRAVETMKKELTLLKS
LVKTEKFLNKLRATLGLVDGYDNNIKSLSYEIVSLEEQLLRLKNS
>BRE_1089 uncharacterized conserved protein
MLNKTNTELGLIVLKNLIEFFVYSDTQDDELFQTGIKKVIDIYKYMNNIY
TRSLQKMEMKESKQIVLELETILSKIAKLIDAINTDADTTLIEDLRFERN
NLIEIKTKLLQEELDKINSKNKKGGQK
>BRE_1081 hypothetical protein
MYFLVKNDNMNYKITLPSKSVKGECLMKKIILSAFVALFTLISCGDKKVD
PSKYGTGTGINYVKFIQDPDKVVALAKNFNDIKDALPKETTDKPYKEANL
TAAFTAISAHEAKFLKALALEKARKSAKENENANSTEIDKEFETYLTENL
KFAKGDANVDGSYASVMKKFTDELVK
>BRE_1002 hypothetical protein
MQHAKSTIEQELKDTKKTLKSEQAKLLYAQSGILQDKIKEKETILNELFQ
LTSQISSDNNPNNSITNSNRYEKFPASYGHGLGIPLVSFSILMEVDRHFF
TQYFNDQAIAATFKYNKDRIYPILLGVTRIYDAYQKLKQKDYYTKQDENY
KKMKEYSDVTSNFLYNINSMIPSLNYQNMLDDIYRNIHKVKINATIEELS
NIKDQFKKYIQKLLETANKIHRRVNSVRFQQFNVLPETEEYYKVFKSIND
DDLQQEIKTTNDYFSECMAYVRSIIKRVIPQES
>BRE_1039 transposase IS200-like protein
MYMSHKLTFNNHCVYSINYHLVLVTKYRHKCINAELSSSFYQIILNICSL
WKITLNEFNHDKDHIHLLLEFIPNIQPSTFINNLKTVSSRLIRKKYSTHL
DKYYWKPYFWSRSYCLISTGGASIDIIKKYIQNQNKSIY
>BRE_1107 hypothetical protein
MKEVKEIKFPKRKNLKAEEMDIEDFIAQVDYTTMQLDREFREFQRQYGSD
KSLDDWMVHMEQENQIQNKKIQETSETLSSRFAKKLNGVIGKD
>BRE_1094 putative lipoprotein
MQRNNILLAVILMLFIGCDLDSGIGLLRGVLDKLDGKSISSDGMIDFKND
DINVINGKDKGNLVKREELVPNVEGLVPNVAEEKYLEPGDIDINDIDNID
VDKINDYTYPWDSSPKSFRILFKKLDKAQQRVQYAYDIWDKACSARNVAY
EFYSKALVALGEFVNAKDENGKNGISDTDNKHFELTKEVDRKWDDYQKAV
AEEERTREDCKESR
>BRE_1062 uncharacterized conserved protein
MMDAINLAIVRNMKRYTQPMFLFKKNLIKNRTNFSYEIKIDKTTPIKFDG
VFLPSGESNIELFDSNIFVKEIHAKTYTLDILDFNSGEQLLVGNDIMEIL
SVSRHLNFSLNQRFRYIVLMLRKL
>BRE_1079 p23-like cell envelope protein
MHTKTLLPIITTMFFIQCNNATDEQIQYKIKIPKESNTIHDKFLSNINNL
TSNTSNKQINSKSILTQLIQKPYETLERNKLITIPLLFLSTKLTVTWIKN
KAISIKGEDGKPLNELINKIRYSYSISPIKENEKLSSNIMPIVLFETTQN
GQDLEVTSFTLTDEPNLDFNTRQYSSLTSLFYTPPKTETSQESGYVNAHP
FWIANKNNEVIKALTKNQSIKAKIKVQNKNSKVTTKYNIMLESHYLSQLI
KDTLQKYPEINTIAPKFKLL
>BRE_1088 putative lipoprotein
MNKKSIVNLIILLQFITFSCKSIASLTNEPEPPIEPTLKNLSIYETQLTS
YVLYFETFLIRAKQKFPNYNFPPFTLFDPKNLKEEHTLQTIKENIKHLKH
YINTTKPIAIDVYKKCSKLKK
>BRE_1092 uncharacterized conserved protein
MRIVFDKETGIITKSIEEIQNIKKEILKREYNILIKDNSIFDIINYPSSA
IDMEIIQALNELFETLKEGGKYFKKLQHSLSIYKSSTYKAVKQTLLAIPQ
IEYANIISSAGTIQIYIIFTKEYRTLSAITQDIKIQIWKAIYNTAPCGTA
FRGKIKLEFFNKNGQQKTYKFSLGIIKYAYLKVLYKTETESIHKEIDENI
REIYKKIFQNKYKDMGISFCYQDLLGPVSLLQGIRKMKIGIHTKENLNTK
ITEIKESEFQFNNDIEIKANELISFDENSRLIIERE
>BRE_1044 uncharacterized conserved protein
MKRIALMFSMCVMSLIFIILACDPMVFIKEMESRDRAYAILRDTVLTYKK
RVISLFDDFQKLSYEFNIPFEKFIPVFSLPDSRNNVYAAFEYDVASLERL
VKICEKFDITSDMMDADTKLIYDLLYLLKEIAEPIDEIINVHLRDEHLSR
ISTTRSASSISVITVALRDSITKERELVFKIKERILAIDPAGIKQVIVIQ
IRDILDDGNINANIRFIKEMARRISRAVR
>BRE_1080 p23-like cell envelope protein
MNTKILLSIPTVVICTQCNNTTNEKLQYEENLSREIISRRKEYIEKFEDL
QSRTTNPTEELNKTLKEPYETIEGNKSITIPILFMHKTINITWIKNKALT
INGLDSKPISELQNKIRYSYSISPIKEDGALSNKIMPIVLFETTQNGQDF
EVTSFTLIDAPNLDFNTRKYSAVSSLFYTPPKTEKSQESGYVNAYPFWIA
NKNNEVIKALTQSRLIRAKIKVKNPKTRFAEEYNIELDTQYLILLITDVL
QKNPGLSKVAPNFNLK
>BRE_1082 bsr, bsr protein
MFENKYLTLKQKEVLRDIDNNFCSKIIFNGGISSGKTFLASYLLIKLLII
NRDNYHKDTNNFIFGSSIGTLLANTLKQIEKICSLLNIEYLLKDSRQVTC
TIAGLTLNIYGGKNIDSFTKIRGSNSALVYVNEATLMHKETLLEIMKRLR
QKPGIIIFDTNPDHPAHYFKVDYIDNRDVYRTYNFSIYDNPLNSKDFIKT
QEAIYKNLSAYKARVLLGEWTASIDSCFNEVILNCEYTFKSPIMYIDPAF
SVGMDNTAICVFEKMGDKYYAYIYQDKKPISDESILHAISVFAEDFNINT
LYIEDRDNTDRYEFLTKIMTSLRLNMNHYFKISAVKPLSNKFVRICTLIP
LFNARSIEFLKITDKNVINDIYSYNGLSRCRDDALDALSACYLLLSLKYH
DKIKHFSMSRYI
>BRE_1108 guaA, GMP synthase (glutamine-hydrolysing) (glutamine amidotransferase)
MSNNAVVILDFGSQYSQLIARKIREMGVYTIIVTYSLSAKEIKDMNPVGL
ILSGGPASVYLDEAPGVDIEIFDLGIPILGICYGMQLIIKVFEGVISKCD
KQEFGHTELFIDDNKADLFLELPSKFEVMMSHGDNIEKIPEGFKQIAYTK
ICVGAVFNLEKRIYGVQFHPEVSCCDIGNQIFMNFVFKICKAQTNWDLSN
SIEDLVKGIRHEVGDSKVILGLSGGIDSLVCALLINKAIKDNLICVFVDT
GFLRKNEANGILEFNKKYNLNIKHIDSSLLFLTNLRDVDDPEEKRKIIGK
TFVEIFEKVALEEDDIKYLAQGTIYSDVIESDVKNNVCSSTNIKSHHNVG
GLPDKINLNLLEPLRNLFKDEVIQLGVQLGLEEEVLYRHPFPGPGLAIRI
IGEITKDKIDILQGADHIFIEELLINDLYYKVRQAFVVLLPVRTVGVMGD
NRTYEYTAVIRCVNTLDFMTASWVELPYSFLRKVSSRIINEIRGINRVCY
DISSKPPATIEWE
>BRE_1046 nrdE, ribonucleoside-diphosphate reductase, alpha subunit
MSYLEHHMMLRILWKGLVMRHLELNNEMMVLRDGFYRLEKDLEALSVFLE
EIKSKSLKFENPNKRMHYLIDNNLYEDFYQKYSEDQILEIYKAVEGEEFK
FKSYMSASKFYKDYALKVKDTYFESYEDRIIAVSLFLADGCFDFALRLAL
DMIKQRYQPATPTFLNAGKYVRGELVSCFLLEVGDSLNSITFNISSAMQL
SKIGGGVALNLSNIRARGEEIRGICNVAKGVIPVMKLLEDGFNYADQMGQ
RKGAGAVYLNIFHYDIEDFLDTKKINADEKSRVQTLSLGVIIPDKFFELA
KQDKNYYALAPYSVYKETGLMMNDIDFDKDYDLLASNPRIIKKEISARDM
LVRIAKLQFESGYPYIMYQTSCNLNHPLKEVGRVKMSNLCTEIFQIQTPS
VIGNYGEGDVIGYDVSCILGSLNIVNVINSDFEFIVDLAMRALTSVVDKS
CINNAPSVRKANDDYRAVGLGVMNLHGFLIKNKIPYESDEALDFVRTFFM
LLNFYSLKSSMNIAKERNSVFKDFKQSEYYNGNYFNMYLNEDFSPRSEVV
REIFSCLQIPSKSDWNNLKGDIQRYGLYHAYRLAVAPTQSISYIQNATTS
LMPIVEPVEARVYGNSTTYYPMPYLSRENAIFFKSAYYMDMRKLIDLVSE
AQRHVDQGISTLLYVTNETSTRELVKLYIYAKNKGLKSLYYTRNKNLSVD
ECILCAI
>BRE_1045 nrdF, ribonucleoside-diphosphate reductase, beta subunit
MRKNREAINWNRLNNGYTKMFWDQNIRQFWVDEEIPISDDKLVWNTLSVD
ERDVYEKVLGGLTLLDTEQGSVGMPRIALAIDNLDYKPILGFMGAMEHMH
AKSYSSIFSSLSNIDRIDYIFDWVKTYRNYQEKLELILGKYNNIHDRMSL
YQALCTSVFLETFLFYSGFFYPLYLAGQGKMVNSGEIINLILRDESVHGV
FVGLLAQEEFDKMTMKEQELAYKEMLLILEKLYSLEREYTKELYSCVGLE
SAVDVFVRYNADKALMNLGFDTKFNIKDTDVNPLVLNGLRTDTKTHDFFS
TKGNGYIKPMRVEPLHDDDFM
>BRE_1047 nrdI, ribonucleoprotein
MVYASKTGNIGRFISKTGLGNIFRIVTGDEIVEEPYVLLTYTIAFGKVPS
EVDKFLEHNFKLMIGVAGSGNKNWGDSFCNAVNLIKDKYGVPEILKFELS
GTSHDVKNFMERISDETLRVK
>BRE_1085 pf32, PF32 plasmid partition protein
MDRKETKVITVASIKGGVGKSTTSLIFATLLSQSFKVLIIDIDTQASTTS
YYFKIIKERGVDLFNRNIYEVLISNLHIDNAVVNVNSNLDLIPSYLTLHK
FNSESIPYKEFRLKEQLKLLEFEYDYIILDTNPSLDFTLTNALVCSSYII
VPITAEKWAVESLDLFNFFIDKLSIKAPIYLINTKFKRNNTHKELLNILK
ENDNFLGTISEREDLNRKIARNDVFDLNKDYIREYQNTLSVLMDKIKNFV
V
>BRE_1084 pf49, PF49 plasmid partition protein
MEMGIEVNKRNLTQNISSEEQVSIHYNKLKERLKINFQKEIFCKIEAMKV
LKEIKDNEYYKLDNYASFDDFAKDYRLARTQTYKYLKIATAIEEGIVEEK
YVINNGINGTMFLLRNKEGVNIKRSKQNPLRPLRFQLKCPDAYAFYKKNA
KLTSFLLERVFSDEKEFLAKIVTQFESSKRVKN
>BRE_1105 pncA, pyrazinamidase/nicotinamidase (pncA)
MKSTFFHLVLNNSALILVDIQNDFLQSGALPVPDGRDIIPLVNKLQNCFK
HVIATKDWHPENHISFLSETNINGWPKHCVQNTWGAAFPKDLDVEKIKAI
FLKGQDQNYDSYSGFYDDCNKKNPTGLLKYLKNNEICVVFIAGLALDFCV
KETLIDAHNLGFKTYLIIDATKSISDFPELIIIELKKLGILTCFSKDILI
NCDL
>BRE_1086 ppap1, plasmid partitioning associated protein-1
MVALLELLKQKKKEIDPKNQKKGKNIFSKVEEINNRKIYHTKIFNDFYAF
GISKNEPTKFFISLRGIFNIEDISMFHLFSIRDDDNFLGIYYGIKKLDKA
FLVKNFNKRETYTLRKCEYIEFRFKKGGVFCYLSGLHNLLKKGKIGSSYY
QTLLSILLELERKLYAFYGKKLPEGGIVPRWIEKRQK
>BRE_1087 ppap2, plasmid partioning associated protein 2
MEIKKIKGKTNRYQYNLIVLISTLNFMNLKLKQYTQTNILYFFNGNLTRN
KQQKVKIKTLQNYLYELEKKYKITLNYCKHLGKQCGSEIYYKLKYPKKTC
HTKINQYFRNIKKEKIDKFTKRIETYIQENGSPKWECINNINNNKKIEER
ILKKYISKCHFKIDLPLVLLNSKIEKDLKIELIKEIKKYERAIEALSLDE
INLLKGKLIEGTPNCVKGFLEGMGYLKNIESKIKRQEIKQKELKEILDLK
RKELESQNYKEDVLNQEINKIYERYKNKPHFIIEQDKYRDLDLLIQKIKK
NTEKCKSKTKERDDIKNNIFSILLEQLRHKFDIGILVPTLKKFINAQDEL
KYSKVVDNTYYYELLDTIK